Antiamoebic drugs for treating amoebic colitis
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Antiamoebic Drugs for Treating Amoebic Colitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450359/all/Antiamoebic_drugs_for_treating_amoebic_colitis.
Antiamoebic drugs for treating amoebic colitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450359/all/Antiamoebic_drugs_for_treating_amoebic_colitis. Accessed October 18, 2019.
Antiamoebic drugs for treating amoebic colitis. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/450359/all/Antiamoebic_drugs_for_treating_amoebic_colitis
Antiamoebic Drugs for Treating Amoebic Colitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450359/all/Antiamoebic_drugs_for_treating_amoebic_colitis.
TY - ELEC
T1 - Antiamoebic drugs for treating amoebic colitis
ID - 450359
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450359/all/Antiamoebic_drugs_for_treating_amoebic_colitis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine